PeptideDB

(Rac)-ABT-202 diHCl 1258641-38-1

(Rac)-ABT-202 diHCl 1258641-38-1

CAS No.: 1258641-38-1

(Rac)-ABT-202 diHCl is the racemate of ABT-202. ABT-202 is an agonist of nicotinic acetylcholine receptors (nAChRs) and
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

(Rac)-ABT-202 diHCl is the racemate of ABT-202. ABT-202 is an agonist of nicotinic acetylcholine receptors (nAChRs) and can be used as an analgesic.

Physicochemical Properties


Molecular Formula C9H15CL2N3
Molecular Weight 236.141499757767
Exact Mass 235.064
CAS # 1258641-38-1
PubChem CID 50988405
Appearance Light brown to brown solid powder
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 1
Heavy Atom Count 14
Complexity 149
Defined Atom Stereocenter Count 0
SMILES

Cl.Cl.N1(C2C=NC=CC=2)CCC(C1)N

InChi Key UPJISLUDXYKVQF-UHFFFAOYSA-N
InChi Code

InChI=1S/C9H13N3.2ClH/c10-8-3-5-12(7-8)9-2-1-4-11-6-9;;/h1-2,4,6,8H,3,5,7,10H2;2*1H
Chemical Name

1-pyridin-3-ylpyrrolidin-3-amine;dihydrochloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Jain KK. Modulators of nicotinic acetylcholine receptors as analgesics. Curr Opin Investig Drugs. 2004 Jan;5(1):76-81.


Solubility Data


Solubility (In Vitro) DMSO : ~33.33 mg/mL (~141.15 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (10.59 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 2.5 mg/mL (10.59 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.2348 mL 21.1739 mL 42.3478 mL
5 mM 0.8470 mL 4.2348 mL 8.4696 mL
10 mM 0.4235 mL 2.1174 mL 4.2348 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.